Domvanalimab, Zimberelimab, Paclitaxel, Carboplatin — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
Study of Novel Treatment Combination Therapies in Participants With Head and Nec
Phase 2 · Head and Neck Squamous Cell Carcinoma |
GILD GILEAD SCIENCES, INC. | Domvanalimab, Zimberelimab, Paclitaxel, |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-31
Sponsor-projected date — can change
|